{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:25:34Z","timestamp":1762442734582,"version":"build-2065373602"},"reference-count":24,"publisher":"Mattioli1885","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction: Psoriasis is an inflammatory skin disease characterized by erythematous, scaly, and well-demarcated pruritic plaques on the extensor areas of the extremities. Psoriasis is one of the most common dermatological diseases in the geriatric population. Objective: The aim of this investigation is to evaluate the demographic data, clinical characteristics, and treatment responses of the geriatric population (\u226560 with psoriasis at our hospital. Methods: In this study, we examined 221 geriatric patients diagnosed with psoriasis. We evaluated patients in 2 groups: early-onset (&lt;60 years) and elderly-onset (\u226560 years). Results: In our study, 50.7% of the patients were female, the average age was 65.9 years., and 76.4% of the patients were considered early-onset. There was no significant difference in terms of the initial body areas affected by the disease between the early-onset and elderly-onset groups; 45.7% of patients had nail psoriasis, while 27.1% had psoriatic arthritis. Nail involvement (p = 0.021) and the presence of psoriatic arthritis (p = 0.011) were more common in the early-onset group. Systemic treatment was predominantly initiated as the first treatment agent in the elderly-onset group (p = 0.014). Patients in the early-onset group received more cyclosporine treatment than the others (p=0.01). Conclusions: The geriatric population is associated with multiple comorbidities and polypharmacy, highlighting the importance of evaluating patients' medications and comorbidities when selecting a treatment agent for psoriasis.<\/jats:p>","DOI":"10.5826\/dpc.1501a4511","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:27:14Z","timestamp":1738153634000},"page":"4511","source":"Crossref","is-referenced-by-count":0,"title":["Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital"],"prefix":"10.5826","volume":"15","author":[{"given":"Elif","family":"\u00c7al\u0131\u015fkan","sequence":"first","affiliation":[{"name":"Gazi University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf Can","family":"Edek","sequence":"additional","affiliation":[{"name":"Gazi University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuray","family":"Keskin","sequence":"additional","affiliation":[{"name":"Yenimahalle Training and Research Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petek","family":"\u00dcst\u00fcn","sequence":"additional","affiliation":[{"name":"Gazi University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Ad\u0131\u015fen","sequence":"additional","affiliation":[{"name":"Gazi University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27750","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"10.5826\/dpc.1501a4511_ref1","doi-asserted-by":"crossref","unstructured":"Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082. Published 2016 Nov 24. DOI:10.1038\/nrdp.2016.82","DOI":"10.1038\/nrdp.2016.82"},{"key":"10.5826\/dpc.1501a4511_ref2","unstructured":"Nair PA, Badri T. Psoriasis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 3, 2023."},{"key":"10.5826\/dpc.1501a4511_ref3","doi-asserted-by":"crossref","unstructured":"Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM; Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(2):243-258. DOI:10.1111\/bjd.19169","DOI":"10.1111\/bjd.19169"},{"key":"10.5826\/dpc.1501a4511_ref4","doi-asserted-by":"crossref","unstructured":"Tseng IL, Yang CC, Lai EC, Lee CN. Psoriasis in the geriatric population: A retrospective study in Asians. J Dermatol. 2021;48(6):818-824. DOI:10.1111\/1346-8138.15737","DOI":"10.1111\/1346-8138.15737"},{"key":"10.5826\/dpc.1501a4511_ref5","doi-asserted-by":"crossref","unstructured":"Balato, N., Patruno, C., Napolitano, M. et al. Managing Moderate-to-Severe Psoriasis in the Elderly. Drugs Aging 31, 233\u2013238 (2014). DOI:10.1007\/s40266-014-0156-6","DOI":"10.1007\/s40266-014-0156-6"},{"key":"10.5826\/dpc.1501a4511_ref6","doi-asserted-by":"crossref","unstructured":"Chen C, Che K, Guo Y, Huang Q, Hu X, Yu B. Effect of the age of onset on epidemiology, clinical features, and comorbidity of geriatric psoriasis [published online ahead of print, 2023 Jun 22]. J Dermatol. 2023;10.1111\/1346-8138.16856. DOI:10.1111\/1346-8138.16856","DOI":"10.1111\/1346-8138.16856"},{"key":"10.5826\/dpc.1501a4511_ref7","doi-asserted-by":"crossref","unstructured":"Yamazaki F. Psoriasis: Comorbidities. J Dermatol.2021;48(6):732-740. DOI:10.1111\/1346-8138.15840","DOI":"10.1111\/1346-8138.15840"},{"key":"10.5826\/dpc.1501a4511_ref8","doi-asserted-by":"crossref","unstructured":"Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76(3):377-390. DOI:10.1016\/j.jaad.2016.07.064","DOI":"10.1016\/j.jaad.2016.07.064"},{"key":"10.5826\/dpc.1501a4511_ref9","doi-asserted-by":"crossref","unstructured":"Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review. Front Immunol. 2022;13:880201. Published 2022 Jun 10. DOI:10.3389\/fimmu.2022.880201","DOI":"10.3389\/fimmu.2022.880201"},{"key":"10.5826\/dpc.1501a4511_ref10","doi-asserted-by":"crossref","unstructured":"Reid C, Griffiths CEM. Psoriasis and Treatment: Past, Present and Future Aspects. Acta Derm Venereol. 2020;100(3):adv00032. Published 2020 Jan 30. DOI:10.2340\/00015555-3386","DOI":"10.2340\/00015555-3386"},{"key":"10.5826\/dpc.1501a4511_ref11","doi-asserted-by":"crossref","unstructured":"van Winden MEC, ter Haar ELM, Groenewoud HMM, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK. Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups. Acta Derm Venereol. 2020;100(14):adv00215. Published 2020 Jul 28. DOI:10.2340\/00015555-3569","DOI":"10.2340\/00015555-3569"},{"key":"10.5826\/dpc.1501a4511_ref12","doi-asserted-by":"crossref","unstructured":"Megna M, Camela E, Battista T, et al. Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opin Drug Saf. 2023;22(1):43-58. DOI:10.1080\/14740338.2023.2173171","DOI":"10.1080\/14740338.2023.2173171"},{"key":"10.5826\/dpc.1501a4511_ref13","doi-asserted-by":"crossref","unstructured":"Piaserico S, Conti A, Lo Console F, et al. Efficacy and safety of systemic treatments for psoriasis in elderly patients. Acta Derm Venereol. 2014;94(3):293-297. DOI:10.2340\/00015555-1719","DOI":"10.2340\/00015555-1719"},{"key":"10.5826\/dpc.1501a4511_ref14","doi-asserted-by":"crossref","unstructured":"Trettel A, Spehr C, K\u00f6rber A, Augustin M. The impact of age on psoriasis health care in Germany. J Eur Acad Dermatol Venereol. 2017;31(5):870-875. DOI:10.1111\/jdv.14115","DOI":"10.1111\/jdv.14115"},{"key":"10.5826\/dpc.1501a4511_ref15","doi-asserted-by":"crossref","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20(6):1475. Published 2019 Mar 23. DOI:10.3390\/ijms20061475","DOI":"10.3390\/ijms20061475"},{"key":"10.5826\/dpc.1501a4511_ref16","doi-asserted-by":"crossref","unstructured":"Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005;11(1):43-49. DOI:10.1038\/nm1162","DOI":"10.1038\/nm1162"},{"key":"10.5826\/dpc.1501a4511_ref17","doi-asserted-by":"crossref","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019;20(18):4347. Published 2019 Sep 5. doi:10.3390\/ijms20184347","DOI":"10.3390\/ijms20184347"},{"key":"10.5826\/dpc.1501a4511_ref18","doi-asserted-by":"crossref","unstructured":"Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57(10):1165-1172. DOI:10.1111\/ijd.14032","DOI":"10.1111\/ijd.14032"},{"key":"10.5826\/dpc.1501a4511_ref19","doi-asserted-by":"crossref","unstructured":"Zhou S, Yao Z. Roles of Infection in Psoriasis. Int J Mol Sci. 2022;23(13):6955. Published 2022 Jun 23. DOI:10.3390\/ijms23136955","DOI":"10.3390\/ijms23136955"},{"key":"10.5826\/dpc.1501a4511_ref20","doi-asserted-by":"crossref","unstructured":"Weatherhead SC, Farr PM, Jamieson D, et al. Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. J Invest Dermatol. 2011;131(9):1916-1926. DOI:10.1038\/jid.2011.134","DOI":"10.1038\/jid.2011.134"},{"key":"10.5826\/dpc.1501a4511_ref21","doi-asserted-by":"crossref","unstructured":"Zaiem A, Daldoul M, Badri T, et al. De novo psoriasis induced by ChAdOx1-S COVID 19 vaccine. Therapie. 2023;78(4):446-447. DOI:10.1016\/j.therap.2022.07.008","DOI":"10.1016\/j.therap.2022.07.008"},{"key":"10.5826\/dpc.1501a4511_ref22","doi-asserted-by":"crossref","unstructured":"Ad\u0131\u015fen E, Uzun S, Erduran F, G\u00fcrer MA. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis. An Bras Dermatol. 2018;93(2):205-211. DOI:10.1590\/abd1806-4841.20186168","DOI":"10.1590\/abd1806-4841.20186168"},{"key":"10.5826\/dpc.1501a4511_ref23","doi-asserted-by":"crossref","unstructured":"Fatema F, Ghoshal L, Saha A, Agarwal S, Bandyopadhyay D. Early-Onset Versus Late-Onset Psoriasis: A Comparative Study of Clinical Variables, Comorbidities, and Association with HLA CW6 in a Tertiary Care Center. Indian J Dermatol. 2021;66(6):705. DOI:10.4103\/ijd.ijd_45_21","DOI":"10.4103\/ijd.ijd_45_21"},{"key":"10.5826\/dpc.1501a4511_ref24","doi-asserted-by":"crossref","unstructured":"Kwon HH, Kwon IH, Youn JI. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype? Int J Dermatol. 2012;51(1):53-58. DOI:10.1111\/j.1365-4632.2011.04979.x","DOI":"10.1111\/j.1365-4632.2011.04979.x"}],"container-title":["Dermatology Practical &amp; Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/4511\/2977","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/4511\/3427","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/4511\/2977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:23:29Z","timestamp":1762442609000},"score":1,"resource":{"primary":{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/view\/4511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1501a4511","relation":{"has-manifestation":[{"id-type":"other","id":"1-78-4511-g2977","asserted-by":"subject"},{"id-type":"other","id":"1-78-4511-g3427","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.v15i1","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"type":"electronic","value":"2160-9381"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"article-number":"6"}}